NCT03833726View on ClinicalTrials.gov

Light Emitting Diode for theTreatment of Genitourinary Syndrome of Menopause Associated With Breast Cancer Treatment

NACompletedINTERVENTIONAL
Enrollment

77

Participants

Timeline

Start Date

January 30, 2019

Primary Completion Date

April 20, 2023

Study Completion Date

September 30, 2023

Conditions
Atrophy;VaginalBreast Cancer
Interventions
PROCEDURE

Experimental: LED group

5 Sessions of 8 minute 405 nm Blue Light Emitting Diode, LED, with a power of 1.66 W / m2, 7 days apart.

PROCEDURE

Sham Comparator: Control

5 Sessions of 8 minute with device off and heated gel, 7 days apart.

Trial Locations (1)

40.290-000

Centro de Atenção ao Assoalho Pelvico, Salvador

All Listed Sponsors
lead

Centro de Atenção ao Assoalho Pélvico

OTHER

NCT03833726 - Light Emitting Diode for theTreatment of Genitourinary Syndrome of Menopause Associated With Breast Cancer Treatment | Biotech Hunter | Biotech Hunter